Resultats de la cerca - Behzad Kharabi Masouleh

  • Mostrar 1 - 10 resultats de 10
Refinar resultats
  1. 1
    Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia

    Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia per Vincent T. Bicocca, Bill H. Chang, Behzad Kharabi Masouleh, Markus Müschen, Marc Loriaux, Brian J. Druker, Jeffrey W. Tyner

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia

    Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia per Behzad Kharabi Masouleh, Huimin Geng, Christian Hurtz, Lai N. Chan, Aaron C. Logan, Mi Sook Chang, Chuanxin Huang, Srividya Swaminathan, Haibo Sun, Elisabeth Paietta, Ari Melnick, Phillip Koeffler, Markus Müschen

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity

    Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity per Behzad Kharabi Masouleh, Gerdy B. ten Dam, Martin K. Wild, Ruth Seelige, Johan van der Vlag, Angelique L. Rops, Frank Echtermeyer, Dietmar Vestweber, Toin H. Van Kuppevelt, Ludwig Kiesel, Martin Götte

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure

    Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure per Susanne Ziegler, Thomas Schettgen, Fabian Beier, Stefan Wilop, Natalia Quinete, André Esser, Behzad Kharabi Masouleh, Mónica S. Ventura Ferreira, Lucia Vankann, Peter Uciechowski, Lothar Rink, Thomas Kraus, Tim H. Brümmendorf, Patrick Ziegler

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

    Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia per Haibo Sun, De‐Chen Lin, Xiao Guo, Behzad Kharabi Masouleh, Sigal Gery, Qi Cao, Serhan Alkan, Takayuki Ikezoe, Chie Akiba, Ronald Paquette, Wenwen Chien, Carsten Müller‐Tidow, Yang Jing, Konstantin Agelopoulos, Markus Müschen, H. Phillip Koeffler

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia per Alan S. Wayne, Van Huynh, Nobuko Hijiya, Rayne H. Rouce, Patrick A. Brown, Joerg Krueger, Carrie L. Kitko, Edward Ziga, Michelle L. Hermiston, Michael K. Richards, André Baruchel, Petra Schuberth, John M. Rossi, Lang Zhou, Lovely Goyal, Rajul K. Jain, Remus Vezan, Behzad Kharabi Masouleh, Daniel W. Lee

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia

    Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia per Thomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, Sandra Cauwenberghs, Peter Fraisl, Christa Maes, Bart Jonckx, Kim De Keersmaecker, Maria Kleppe, Marc Tjwa, Thomas Schenk, Stefan Vinckier, Rita Fragoso, Maria De Mol, Karolien Beel, Sérgio Dias, Catherine M. Verfaillie, Richard E. Clark, Tim H. Brümmendorf, Peter Vandenberghe, Shahin Rafii, Tessa L. Holyoake, Andreas Hochhaus, Jan Cools, Michael Karin, Geert Carmeliet, Mieke Dewerchin, Peter Carmeliet

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external hist... per Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

    KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study per Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Chaoling Feng, Jinghui Dong, Tong Shen, Francesca Milletti, John M. Rossi, Remus Vezan, Behzad Kharabi Masouleh, Roch Houot

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

    Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease per Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx, Hajimu Oura, Annemilaï Tijeras‐Raballand, Thomas Schmidt, Sonja Loges, Imke Albrecht, Bart Jonckx, Stefan Vinckier, Christophe Van Steenkiste, Sònia Tugues, Charlotte Rolny, Maria De Mol, Daniela Dettori, Patricia Hainaud, Lieve Coenegrachts, J.O. Contreres, Tine Van Bergen, Henar Cuervo, Wei-Hong Xiao, Carole Le Hénaff, Ian Buysschaert, Behzad Kharabi Masouleh, Anja Geerts, Tibor Schomber, Philippe Bonnin, Vincent Lambert, Jurgen Haustraete, Serena Zacchigna, Jean-Marie Rakic, Wladimiro Jiménez, Agnès Noël, Mauro Giacca, Isabelle Colle, Jean-Michel Foidart, G Tobelem, Manuel Morales‐Ruiz, José Vilar, Patrick H. Maxwell, Stanley A. Vinores, Geert Carmeliet, Mieke Dewerchin, Lena Claesson‐Welsh, Évelyne Dupuy, Hans Van Vlierberghe, Gerhard Christofori, Massimiliano Mazzone, Michael Detmar, Désiré Collen, Peter Carmeliet

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: